|
Kewaunee Scientific Corporation (NASDAQ: KEQU) |
|
Kewaunee Scientific Corporation
KEQU's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Kewaunee Scientific growth rates, revenue grew
by 44.21 % in the third quarter of 2025 from the same quarter a year ago.
Ranking at No. 2166
Laboratory Analytical Instruments industry recorded
growth of revenues by 1.33 %
Kewaunee Scientific's net profit decreased by -45.4 % in third quarter of 2025 year on year, to $1 millions.
• More on KEQU's Growth
|
|
Kewaunee Scientific current PE on trailing twelve month basis is below Laboratory Analytical Instruments industry average.
Kewaunee Scientific PEG ratio is at 0.06
Kewaunee Scientific realized cash reduction of $ -4.93 per share in trailing twelve-month period. Laboratory Analytical Instruments industry recorded net loss in trailing twelve months. |
Company |
6.28 |
PE TTM
|
Industry |
10.42 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.5.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 4.1.
• More on KEQU's Valuation
|
|
|
|
|
Kewaunee Scientific current PE on trailing twelve month basis is below Laboratory Analytical Instruments industry average.
Kewaunee Scientific PEG ratio is at 0.06
Kewaunee Scientific realized cash outflow of $ -4.93per share in trailing twelve-month period. Laboratory Analytical Instruments industry recorded net loss in trailing twelve months. |
Company |
6.28 |
PE TTM
|
Industry |
10.42 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.5.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 4.1.
Kewaunee Scientific Price to Book Ratio is at 1.77 lower than Industry Avg. of 225.12. and higher than S&P 500 Avg. of 0.01
• More on KEQU's Valuation
|
|
KEQU's Profitability Comparisons
|
Kewaunee Scientific faced margin deterioration, primarily through cost pressure. Operating Margin fell in third quarter of 2025 to 3.39 % from 9.44 % in II. Quarter.
Kewaunee Scientific net profit margin of 2.08 % is currently ranking no. 10 in Laboratory Analytical Instruments industry, ranking no. 193 in Healthcare sector and number 2236 in S&P 500.
Profitability by Segment |
Total |
2.08 % |
|
|
Kewaunee Scientific faced margin deterioration, primarily through cost pressure. Operating Margin fell in third quarter of 2025 to 3.39 % from 9.44 % in II. Quarter.
Kewaunee Scientific net profit margin of 2.08 % is currently ranking no. 10 in Laboratory Analytical Instruments industry, ranking no. 193 in Healthcare sector and number 2236 in S&P 500.
• More on KEQU's Key Ratios
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com